EUVIMEDEUVIMED entdecken
Crossref

Survey of patients and physicians on shared decision-making in treatment selection in relapsed/refractory multiple myeloma

Carma L Bylund, Susan Eggly, Thomas W LeBlanc, Sandra Kurtin, Marianne Gandee, Rohan Medhekar, Alan Fu, Monica Khurana, Kara Delaney, Alecia Divita, Michelle McNamara, Walter F Baile

Translational Behavioral Medicine · 2023

DOI: 10.1093/tbm/ibac099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Behavioral Medicine, 2023. Verfasst von Carma L Bylund und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL, USA. Hauptthemen laut MEDLINE: Multiple Myeloma, Physicians, Oncologists. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Amgen, Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Shared decision-making (SDM) is a key component of patient-centered healthcare. SDM is particularly pertinent in the relapsed and/or refractory multiple myeloma (RRMM) setting, in which numerous treatment options can present challenges for identifying optimal care. However, few studies have assessed the extent and relevance of SDM and patient-centered communication (PCC) in RRMM. To describe treatment decision-making patterns between physicians and patients in the RRMM setting, we conducted online surveys of patients and physicians in the USA to compare their perspectives on the process of treatment decision-making. We analyzed the surveys descriptively. Two hundred hematologists/oncologists and 200 patients with RRMM receiving second-line (n = 89), third-line (n = 65), and fourth-line (n = 46) therapy participated. Top treatment goals for physicians and patients included extending overall survival (among 76% and 83% of physicians and patients, respectively) and progression-free survival (among 54% and 77% of physicians and patients, respectively), regardless of the number of prior relapses. Thirty percent of physicians believed patients preferred a shared approach to treatment decision-making, while 40% of patients reported most often preferring a shared role in treatment decision-making. One-fourth of patients most often preferred physicians to make the final treatment decision after seriously considering their opinion. Thirty-two percent of physicians and 16% of patients recalled ≥3 treatment options presented at first relapse. Efficacy was a primary treatment goal for patients and physicians. Discrepancies in their perceptions during RRMM treatment decision-making exist, indicating that communication tools are needed to facilitate SDM and PCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaPhysiciansOncologistsHumansDecision MakingPhysician-Patient RelationsPatient Participation

Stichwörter der Autor:innen

Shared decision-makingmultiple myelomapatient-centered communicationtreatment selection

Autor:innen und Institutionen

  • Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Wayne State University Department of Oncology/Karmanos Cancer Institute, Detroit, MI, USA.
  • Duke Cancer Institute, Durham, NC, USA.
  • Division of Hematological Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • University of Arizona and Arizona Cancer Center, Tucson, AZ, USA.
  • Association of Community Cancer Centers, Rockville, MD, USA.

Förderung

  • Amgen, Inc

Zitieren

APA

Bylund, C. L., Eggly, S., LeBlanc, T. W., Kurtin, S., Gandee, M., Medhekar, R., Fu, A., Khurana, M., Delaney, K., Divita, A., McNamara, M., & Baile, W. F. (2023). Survey of patients and physicians on shared decision-making in treatment selection in relapsed/refractory multiple myeloma. Translational Behavioral Medicine. https://doi.org/10.1093/tbm/ibac099

Vancouver

Bylund CL, Eggly S, LeBlanc TW, Kurtin S, Gandee M, Medhekar R, et al. Survey of patients and physicians on shared decision-making in treatment selection in relapsed/refractory multiple myeloma. Translational Behavioral Medicine. 2023. doi:10.1093/tbm/ibac099

BibTeX
@article{Bylund2023,
  author = {Bylund, Carma L and Eggly, Susan and LeBlanc, Thomas W and Kurtin, Sandra and Gandee, Marianne and Medhekar, Rohan and Fu, Alan and Khurana, Monica and Delaney, Kara and Divita, Alecia and McNamara, Michelle and Baile, Walter F},
  title = {Survey of patients and physicians on shared decision-making in treatment selection in relapsed/refractory multiple myeloma},
  journal = {Translational Behavioral Medicine},
  year = {2023},
  doi = {10.1093/tbm/ibac099}
}
Kostenlos starten →